Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Gelber

Showing results (81-90 of 239) with videos related to

Pageof 24
Sort By:
International Journal of Radiation Oncology, Biology, Physics|July 1, 1980
A controlled evaluation of combined radiation and bleomycin therapy for squamous cell carcinoma of the esophagusJ D Earle, R D Gelber, C G Moertel, et al.
The American Journal of Pediatric Hematology/Oncology|May 1, 1993
Pediatric histiocytosis. Characterization, prognosis, and oral involvementD Filocoma, H L Needleman, R Arceci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Adjuvant chemoendocrine therapy in postmenopausal breast cancer: cyclophosphamide, methotrexate, and fluorouracil dose and schedule may make a difference. International Breast Cancer Study GroupA Goldhirsch, A S Coates, M Colleoni, et al.
Lancet (London, England)|June 1, 1985
Endocrine adjuvant therapy for breast cancerA Goldhirsch, R D Gelber, M N Tattersall, et al.
Lancet (London, England)|July 18, 1987
Methotrexate/nitrous-oxide toxic interaction in perioperative chemotherapy for early breast cancerA Goldhirsch, R D Gelber, M N Tattersall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1985
Adjuvant therapy in postmenopausal node-positive breast cancerA Goldhirsch, R D Gelber, F Cavalli, et al.
Haematology and Blood Transfusion|January 1, 1990
More is better! Update of Dana-Farber Cancer Institute/Children's Hospital childhood acute lymphoblastic leukemia trialsS E Sallan, R D Gelber, V Kimball, et al.
Lancet (London, England)|September 12, 2000
Taxanes as adjuvant for breast cancerA Goldhirsch, P Francis, M Castiglione-Gertsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 1998
Adding adjuvant CMF chemotherapy to either radiotherapy or tamoxifen: are all CMFs alike? The International Breast Cancer Study Group (IBCSG)A Goldhirsch, M Colleoni, A S Coates, et al.
Lancet (London, England)|August 11, 2001
Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysisB F Cole, R D Gelber, S Gelber, et al.
Pageof 24

Showing results (81-90 of 239) with videos related to

Sort By:
Pageof 24
International Journal of Radiation Oncology, Biology, Physics|July 1, 1980
A controlled evaluation of combined radiation and bleomycin therapy for squamous cell carcinoma of the esophagusJ D Earle, R D Gelber, C G Moertel, et al.
The American Journal of Pediatric Hematology/Oncology|May 1, 1993
Pediatric histiocytosis. Characterization, prognosis, and oral involvementD Filocoma, H L Needleman, R Arceci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Adjuvant chemoendocrine therapy in postmenopausal breast cancer: cyclophosphamide, methotrexate, and fluorouracil dose and schedule may make a difference. International Breast Cancer Study GroupA Goldhirsch, A S Coates, M Colleoni, et al.
Lancet (London, England)|June 1, 1985
Endocrine adjuvant therapy for breast cancerA Goldhirsch, R D Gelber, M N Tattersall, et al.
Lancet (London, England)|July 18, 1987
Methotrexate/nitrous-oxide toxic interaction in perioperative chemotherapy for early breast cancerA Goldhirsch, R D Gelber, M N Tattersall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1985
Adjuvant therapy in postmenopausal node-positive breast cancerA Goldhirsch, R D Gelber, F Cavalli, et al.
Haematology and Blood Transfusion|January 1, 1990
More is better! Update of Dana-Farber Cancer Institute/Children's Hospital childhood acute lymphoblastic leukemia trialsS E Sallan, R D Gelber, V Kimball, et al.
Lancet (London, England)|September 12, 2000
Taxanes as adjuvant for breast cancerA Goldhirsch, P Francis, M Castiglione-Gertsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 1998
Adding adjuvant CMF chemotherapy to either radiotherapy or tamoxifen: are all CMFs alike? The International Breast Cancer Study Group (IBCSG)A Goldhirsch, M Colleoni, A S Coates, et al.
Lancet (London, England)|August 11, 2001
Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysisB F Cole, R D Gelber, S Gelber, et al.
Pageof 24